News | News By Subject | News by Disease News By Date | Search News

Inflammation (general) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novartis AG (NVS) Granted Three Breakthrough Badges for Ilaris     4/27/2016
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial     6/25/2015
Galapagos (GLPG.BR) Ends Long-Running R&D Inflammation Pact With Janssen Pharmaceutica N.V.     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK)     12/1/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis Pharmaceutical Corporation (NVS) AIN457 (secukinumab) Showed Significant Symptom Improvement In Two Pivotal Phase 3 ankylosing spondylitis Studies     11/17/2014
TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis     10/28/2014
Ablynx (ABLYF)'s Ant-Il-6R Nanobody Partnered With AbbVie (ABBV) Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection     10/23/2014
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million     9/19/2014
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial     7/24/2014
Ablynx (ABLYF) Scores $840 Million Inflammatory Drug Pact With AbbVie (ABBV); Ablynx Stock Rises 24.73% at Market Close (September 23, 2013)     9/23/2013

News from Around the Web
Frequent Nut Consumption Associated With Less Inflammation, Brigham and Women's Hospital Study     8/3/2016
FDA Proposes Ban On Most Powdered Medical Gloves     3/22/2016
The Science Of Why Your Muscles Get Less Sore As You Stick With Your Gym Routine, Brigham Young University Study     2/9/2016
Inflammation Can Fan The Flames Of Depression, Rice University Study     12/21/2015
Inflammation May Bring On Depression Symptoms, Emory University School of Medicine Study     11/23/2015
Could A Pill Make Bacon As Beneficial As Fish Oil? University of Gothenburg Study     8/28/2015
If You Want To Reach 100, Keep Your Inflammation Levels Low, Newcastle University Study     8/10/2015
Drinking Coffee May Lower Inflammation, Diabetes Risk, Harokopio University     7/21/2015
Mothers Can Pass Traits To Offspring Through Bacteria's DNA, Washington University in St. Louis Study     2/23/2015
Yale University School Of Medicine Team Identifies Link Between Inflammation And Type 2 Diabetes     2/10/2015
Use Nature, Art, And Religion To Boost Your Body's Defense System, University of California, Berkeley (CAL) Study     2/6/2015
Personality And Health May Have A Genetic Link, University of Nottingham Study     12/12/2014
Novel Treatment To Decrease Craving In Alcoholics Identified, Université Catholique de Louvain Study     10/31/2014
Over-The-Counter Pain Med May Restore Immune Function In Old Age, Ohio State University Study     9/3/2014
Aspirin's Second Effect: Reduces Inflammation, University of California, San Diego (UCSD) Study     8/20/2014

Press Releases
Pharmalink AB Announces European Orphan Drug Designation For Nefecon For Treatment Of Iga Nephropathy, An Inflammatory Kidney Disease     11/29/2016
Janssen R&D Release: New Phase 3 Data Show SIMPONI ARIA (Golimumab) Significantly Improved Signs And Symptoms In Patients With Active Ankylosing Spondylitis     11/14/2016
Momenta (MNTA) And Mylan (MYL) Initiate Phase 1 Clinical Trial For M834, A Proposed Biosimilar Of ORENCIA (Abatacept)     11/2/2016
Revolutionary Liquid Adult Anti-Inflammatory Vanapain Rebranded As TexaClear     11/2/2016
Dermira (DERM) Presents Data From DRM01 Phase IIb Clinical Program At Annual Meeting For Dermatologists     10/21/2016
Allakos Begins Clinical Trials Of AK002 In Patients With Systemic Mastocytosis     9/15/2016
Promising New Findings For Probiodrug AG's Glutaminyl Cyclase - Inhibitor In An Inflammation Animal Model     9/7/2016
FDA Grants Soligenix (SNGX) Orphan Drug Designation For Dusquetide For Treatment Of Macrophage Activation Syndrome     8/18/2016
Amgen (AMGN) To Discuss Data Supporting Biologics License Application For ABP 501, A Biosimilar Candidate To Adalimumab     7/12/2016
AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial     7/6/2016
Araim Pharmaeuticals Receives Orphan Drug Designation From The US FDA For ARA 290 For The Treatment Of Sarcoidosis     7/5/2016
AbbVie (ABBV)'s HUMIRA (Adalimumab) Receives FDA Approval To Treat Adults With Non-Infectious Intermediate, Posterior And Panuveitis     7/1/2016
Iroko Pharmaceuticals Summarizes Low-Dose SoluMatrix NSAID Efficacy And Safety Data At American Association Of Nurse Practitioners National Conference     6/23/2016
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients     6/21/2016
Prothena (PRTA) Presents First Clinical Data for PRX003 for the Treatment of Inflammatory Diseases     6/10/2016

//-->